These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32957990)

  • 21. Estimates of health utility scores in chronic kidney disease.
    Sekercioglu N; Curtis B; Murphy S; Blackhouse G; Barrett B
    Int Urol Nephrol; 2017 Nov; 49(11):2043-2049. PubMed ID: 28733768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
    Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
    Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
    Richardson J; Khan MA; Iezzi A; Maxwell A
    Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies.
    Palmer SC; Hanson CS; Craig JC; Strippoli GF; Ruospo M; Campbell K; Johnson DW; Tong A
    Am J Kidney Dis; 2015 Apr; 65(4):559-73. PubMed ID: 25453993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing and transforming PROMIS utility values to the EQ-5D.
    Hartman JD; Craig BM
    Qual Life Res; 2018 Mar; 27(3):725-733. PubMed ID: 29264776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.
    Elshahat S; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
    PLoS One; 2020; 15(3):e0230512. PubMed ID: 32208435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
    Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
    Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of health states in chronic kidney disease: a structured review of the literature.
    Dale PL; Hutton J; Elgazzar H
    Curr Med Res Opin; 2008 Jan; 24(1):193-206. PubMed ID: 18039434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).
    Goodwin E; Hawton A; Green C
    Health Qual Life Outcomes; 2019 Aug; 17(1):136. PubMed ID: 31382960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?
    Marra CA; Rashidi AA; Guh D; Kopec JA; Abrahamowicz M; Esdaile JM; Brazier JE; Fortin PR; Anis AH
    Qual Life Res; 2005 Jun; 14(5):1333-44. PubMed ID: 16047508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4.
    Stømer U; Bergrem H; Gøransson LG
    Ann Transplant; 2013 Nov; 18():635-42. PubMed ID: 24241237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of health state utility values using SF-6D for Chinese adult patients with β-thalassemia major.
    Zhang R; Zhang S; Ming J; Xie J; Liu B; Chen C; Sun X; Zhen X
    Front Public Health; 2022; 10():1072866. PubMed ID: 36743186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.
    Habbous S; Przech S; Martin J; Garg AX; Sarma S
    Value Health; 2018 Mar; 21(3):318-325. PubMed ID: 29566839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
    Schwarzinger M; Luchini S;
    Health Qual Life Outcomes; 2019 Jul; 17(1):129. PubMed ID: 31345227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.